Literature DB >> 29103378

Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records.

Theodore R Pak1, Kieran I Chacko1, Timothy O'Donnell1, Shirish S Huprikar2, Harm van Bakel1, Andrew Kasarskis1, Erick R Scott1.   

Abstract

BACKGROUND Reported per-patient costs of Clostridium difficile infection (CDI) vary by 2 orders of magnitude among different hospitals, implying that infection control officers need precise, local analyses to guide rational decision making between interventions. OBJECTIVE We sought to comprehensively estimate changes in length of stay (LOS) attributable to CDI at a single urban tertiary-care facility using only data automatically extractable from the electronic medical record (EMR). METHODS We performed a retrospective cohort study of 171,938 visits spanning a 7-year period. In total, 23,968 variables were extracted from EMR data recorded within 24 hours of admission to train elastic-net regularized logistic regression models for propensity score matching. To address time-dependent bias (reverse causation), we separately stratified comparisons by time of infection, and we fit multistate models. RESULTS The estimated difference in median LOS for propensity-matched cohorts varied from 3.1 days (95% CI, 2.2-3.9) to 10.1 days (95% CI, 7.3-12.2) depending on the case definition; however, dependency of the estimate on time to infection was observed. Stratification by time to first positive toxin assay, excluding probable community-acquired infections, showed a minimum excess LOS of 3.1 days (95% CI, 1.7-4.4). Under the same case definition, the multistate model averaged an excess LOS of 3.3 days (95% CI, 2.6-4.0). CONCLUSIONS In this study, 2 independent time-to-infection adjusted methods converged on similar excess LOS estimates. Changes in LOS can be extrapolated to marginal dollar costs by multiplying by average costs of an inpatient day. Infection control officers can leverage automatically extractable EMR data to estimate costs of CDI at their own institutions. Infect Control Hosp Epidemiol. 2017;38:1478-1486.

Entities:  

Mesh:

Year:  2017        PMID: 29103378      PMCID: PMC5923033          DOI: 10.1017/ice.2017.214

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  37 in total

1.  Electronic health records: an international perspective on "meaningful use".

Authors:  Bradford H Gray; Thomas Bowden; Ib Johansen; Sabine Koch
Journal:  Issue Brief (Commonw Fund)       Date:  2011-11

2.  Pay for preventing (not causing) health care-associated infections.

Authors:  Mitchell H Katz
Journal:  JAMA Intern Med       Date:  2013 Dec 9-23       Impact factor: 21.873

3.  Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures.

Authors:  Guillaume Lonjon; Isabelle Boutron; Ludovic Trinquart; Nizar Ahmad; Florence Aim; Rémy Nizard; Philippe Ravaud
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

4.  The economic burden of Clostridium difficile.

Authors:  S M McGlone; R R Bailey; S M Zimmer; M J Popovich; Y Tian; P Ufberg; R R Muder; B Y Lee
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

5.  Attributable inpatient costs of recurrent Clostridium difficile infections.

Authors:  Erik R Dubberke; Eric Schaefer; Kimberly A Reske; Marya Zilberberg; Christopher S Hollenbeak; Margaret A Olsen
Journal:  Infect Control Hosp Epidemiol       Date:  2014-09-29       Impact factor: 3.254

6.  Costs associated with health care-associated infections in cardiac surgery.

Authors:  Giampaolo Greco; Wei Shi; Robert E Michler; David O Meltzer; Gorav Ailawadi; Samuel F Hohmann; Vinod H Thourani; Michael Argenziano; John H Alexander; Kathy Sankovic; Lopa Gupta; Eugene H Blackstone; Michael A Acker; Mark J Russo; Albert Lee; Sandra G Burks; Annetine C Gelijns; Emilia Bagiella; Alan J Moskowitz; Timothy J Gardner
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094

7.  The prolongation of length of stay because of Clostridium difficile infection.

Authors:  Brett G Mitchell; Anne Gardner; Adrian G Barnett; Janet E Hiller; Nicholas Graves
Journal:  Am J Infect Control       Date:  2013-12-02       Impact factor: 2.918

8.  Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients.

Authors:  Erik R Dubberke; Kimberly A Reske; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

9.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

10.  How next-generation sequencing and multiscale data analysis will transform infectious disease management.

Authors:  Theodore R Pak; Andrew Kasarskis
Journal:  Clin Infect Dis       Date:  2015-08-06       Impact factor: 9.079

View more
  2 in total

1.  Direct cost of health care for individuals with community associated Clostridium difficile infections: A population-based cohort study.

Authors:  Harminder Singh; Zoann Nugent; A Walkty; B Nancy Yu; Lisa M Lix; Laura E Targownik; Charles N Bernstein; Julia Witt
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

2.  Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.

Authors:  Alexandre R Marra; Eli N Perencevich; Richard E Nelson; Matthew Samore; Karim Khader; Hsiu-Yin Chiang; Margaret L Chorazy; Loreen A Herwaldt; Daniel J Diekema; Michelle F Kuxhausen; Amy Blevins; Melissa A Ward; Jennifer S McDanel; Rajeshwari Nair; Erin Balkenende; Marin L Schweizer
Journal:  JAMA Netw Open       Date:  2020-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.